These results demonstrated that AML can be generated in immuno-competent mice by a synonymous mutant of MLL-AF4 and suggested that post-transcriptional regulation plays a critical role in controlling the oncogenic activity of MLL-AF4. The gene discussed is KMT2A; the disease is acute myeloid leukemia.